Snowball logo
logo
4XC1_logo

KalVista Pharmaceuticals Inc

11.60-1.40  (10.77%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and support your passive income strategy with tools and community of investors
Start

Frequently asked questions

What sector does KalVista Pharmaceuticals Inc (4XC1) operate in?

KalVista Pharmaceuticals Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is KalVista Pharmaceuticals Inc (4XC1) current stock price?

As of the latest data, KalVista Pharmaceuticals Inc stock price is €11.60, with a previous close of €13.00. KalVista Pharmaceuticals Inc lost -€1.40 in the last trading session, representing a -10.77% loss.

What is KalVista Pharmaceuticals Inc (4XC1) current market capitalization?

KalVista Pharmaceuticals Inc market cap is approximately 579.46 million.

What is KalVista Pharmaceuticals Inc (4XC1) Earnings Per Share (EPS)?

The trailing EPS is -€3.15.

Does KalVista Pharmaceuticals Inc (4XC1) pay dividends?

No. KalVista Pharmaceuticals Inc does not pay a dividend.

When is KalVista Pharmaceuticals Inc (4XC1) next earnings report?

KalVista Pharmaceuticals Inc is expected to release its next earnings report on April 30, 2025.

What is KalVista Pharmaceuticals Inc (4XC1) beta (volatility) score?

KalVista Pharmaceuticals Inc has a beta of -0.021, indicating lower volatility than the overall market.